159 related articles for article (PubMed ID: 14675317)
1. A real time optoelectronic device as an adjunct to the Pap smear for cervical screening: a multicenter evaluation.
Singer A; Coppleson M; Canfell K; Skladnev V; Mackellar G; Pisal N; Deery A
Int J Gynecol Cancer; 2003; 13(6):804-11. PubMed ID: 14675317
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a real-time optoelectronic method in the diagnostics of CIN over four years of observations.
Suchońska B; Gajzlerska-Majewska W; Wielgoś M
PLoS One; 2021; 16(2):e0247702. PubMed ID: 33635909
[TBL] [Abstract][Full Text] [Related]
3. The feasibilities of TruScreen for primary cervical cancer screening: a self-controlled study.
Long S; Lei W; Feng Y; Lv D; Cai Y; Yang P
Arch Gynecol Obstet; 2013 Jul; 288(1):113-8. PubMed ID: 23296464
[TBL] [Abstract][Full Text] [Related]
4. [The diagnostic value of cytology and colposcopy in women with cervical intraepithelial neoplasia].
Wojciech R
Ginekol Pol; 2011 Aug; 82(8):607-11. PubMed ID: 21957606
[TBL] [Abstract][Full Text] [Related]
5. Expression of MN/CA9 protein in Papanicolaou smears containing atypical glandular cells of undetermined significance is a diagnostic biomarker of cervical dysplasia and neoplasia.
Liao SY; Stanbridge EJ
Cancer; 2000 Mar; 88(5):1108-21. PubMed ID: 10699902
[TBL] [Abstract][Full Text] [Related]
6. Natural history of false-negative papanicolaou smears: a prospective study using screening colposcopy in addition to cytology.
Mannino JR
J Am Osteopath Assoc; 1998 Oct; 98(10):542-6. PubMed ID: 9821735
[TBL] [Abstract][Full Text] [Related]
7. [Assesment of real optoelectronic method in the detection of cervical intraepithelial neoplasia].
Pruski D; Kedzia W; Przybylski M; Józefiak A; Kedzia H; Spaczyński M
Ginekol Pol; 2008 May; 79(5):342-6. PubMed ID: 18624109
[TBL] [Abstract][Full Text] [Related]
8. Comparison of two tests for detecting carcinogenic HPV in women with Papanicolaou smear reports of ASCUS and LSIL.
Ferris DG; Wright TC; Litaker MS; Richart RM; Lorincz AT; Sun XW; Woodward L
J Fam Pract; 1998 Feb; 46(2):136-41. PubMed ID: 9487319
[TBL] [Abstract][Full Text] [Related]
9. [Cervical cancer screening by Pap smear: experience of the National Research Center in Reproductive Health. ONFP].
Ben Aissa R; Bennour R; Ben Hamida A; Kammoun N; Mansour H; Mhamdi A; Landoulsi S; Cherif N; Gueddana N
Tunis Med; 2002 Apr; 80(4):203-6. PubMed ID: 12416356
[TBL] [Abstract][Full Text] [Related]
10. [Diagnostic value of TruScreen, cytology and colposcopy].
Atanassova D; Zlatkov V; Borisov S; Veleva G
Akush Ginekol (Sofiia); 2013; 52(3):7-18. PubMed ID: 24283057
[TBL] [Abstract][Full Text] [Related]
11. Combined Pap smear, cervicography and HPV DNA testing in the detection of cervical intraepithelial neoplasia and cancer.
Costa S; Sideri M; Syrjänen K; Terzano P; De Nuzzo M; De Simone P; Cristiani P; Finarelli AC; Bovicelli A; Zamparelli A; Bovicelli L
Acta Cytol; 2000; 44(3):310-8. PubMed ID: 10833984
[TBL] [Abstract][Full Text] [Related]
12. Triage of women with ASCUS and LSIL on Pap smear reports: management by repeat Pap smear, HPV DNA testing, or colposcopy?
Ferris DG; Wright TC; Litaker MS; Richart RM; Lorincz AT; Sun XW; Borgatta L; Buck H; Kramer L; Rubin R
J Fam Pract; 1998 Feb; 46(2):125-34. PubMed ID: 9487318
[TBL] [Abstract][Full Text] [Related]
13. Comparing PAP smear cytology, aided visual inspection, screening colposcopy, cervicography and HPV testing as optional screening tools in Latin America. Study design and baseline data of the LAMS study.
Syrjänen K; Naud P; Derchain S; Roteli-Martins C; Longatto-Filho A; Tatti S; Branca M; Erzen M; Hammes LS; Matos J; Gontijo R; Sarian L; Braganca J; Arlindo FC; Maeda MY; Lörincz A; Dores GB; Costa S; Syrjänen S
Anticancer Res; 2005; 25(5):3469-80. PubMed ID: 16101165
[TBL] [Abstract][Full Text] [Related]
14. Liqui-Prep® versus conventional Papanicolaou smear to detect cervical cells abnormality by split-sample technique: a randomized double-blind controlled trial.
Jesdapatarakul S; Tangjitgamol S; Nguansangiam S; Manusirivithaya S
Diagn Cytopathol; 2011 Jan; 39(1):22-7. PubMed ID: 20063407
[TBL] [Abstract][Full Text] [Related]
15. Visual inspection with acetic acid for cervical cancer screening outside of low-resource settings.
Jeronimo J; Morales O; Horna J; Pariona J; Manrique J; Rubiños J; Takahashi R
Rev Panam Salud Publica; 2005 Jan; 17(1):1-5. PubMed ID: 15720875
[TBL] [Abstract][Full Text] [Related]
16. Comparison of HPV-based assays with Papanicolaou smears for cervical cancer screening in Morelos State, Mexico.
Salmerón J; Lazcano-Ponce E; Lorincz A; Hernández M; Hernández P; Leyva A; Uribe M; Manzanares H; Antunez A; Carmona E; Ronnett BM; Sherman ME; Bishai D; Ferris D; Flores Y; Yunes E; Shah KV
Cancer Causes Control; 2003 Aug; 14(6):505-12. PubMed ID: 12948281
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus (HPV) testing in the management of women with abnormal Pap smears. Experience of a colposcopy referral clinic.
Ciotti M; Sesti F; Paba P; Benedetto A; Patrizi L; Criscuolo A; Piccione E; Branca M; Syrjänen K; Favalli C
Eur J Gynaecol Oncol; 2004; 25(5):577-84. PubMed ID: 15493169
[TBL] [Abstract][Full Text] [Related]
18. The adequacy of management of women with CIN 2 and CIN 3 Pap smear abnormalities.
Towler BP; Irwig LM; Shelley JM
Med J Aust; 1993 Oct; 159(8):523, 526-8. PubMed ID: 8412951
[TBL] [Abstract][Full Text] [Related]
19. P16(INK4a) immunocytochemistry in liquid-based cytology samples in equivocal Pap smears: added value in management of women with equivocal Pap smear.
Monsonego J; Pollini G; Evrard MJ; Sednaoui P; Monfort L; Quinzat D; Dachez R; Syrjänen K
Acta Cytol; 2007; 51(5):755-66. PubMed ID: 17910346
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral.
Kulasingam SL; Hughes JP; Kiviat NB; Mao C; Weiss NS; Kuypers JM; Koutsky LA
JAMA; 2002 Oct; 288(14):1749-57. PubMed ID: 12365959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
